NCT00959816View on ClinicalTrials.gov

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

August 31, 2009

Conditions
Healthy
Interventions
DRUG

ABT-614

Single dose administered on Study Day 1 in Part 1, daily dose administered on Study Days 1-14 in Part 2.

Trial Locations (1)

78217

Site Reference ID/Investigator# 22445, San Antonio

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY